Evidence map›Paper›PMID 26995266›Full record

ReviewInflammation research : official journal of the European Histamine Research Society ... [et al.]2016

Sepsis: in search of cure.

Chikkamenahalli Lakshminarayana Lakshmikanth, Shancy Petsel Jacob, Vyala Hanumanthareddy Chaithra, Hugo Caire de Castro-Faria-Neto, Gopal Kedihithlu Marathe

Abstract readReview
PubMed Publisher
In one paragraph

Review in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Factors Promoting Lipopolysaccharide Uptake by Synthetic Lipid Droplets.bioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Interleukin-33: A Double-Edged Sword in Sepsis.Translational perioperative and pain medicine · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chikkamenahalli Lakshminarayana LakshmikanthDepartment of Studies in Biochemistry, University of Mysore, Manasagangothri, Mysore, 570 006, India.
Shancy Petsel JacobDepartment of Studies in Biochemistry, University of Mysore, Manasagangothri, Mysore, 570 006, India.
Vyala Hanumanthareddy ChaithraDepartment of Studies in Biochemistry, University of Mysore, Manasagangothri, Mysore, 570 006, India.
Hugo Caire de Castro-Faria-NetoLaboratório de Immunofarmacologia, Instituto Oswaldo Cruz, Fundacão Oswaldo Cruz, Rio de Janeiro, Brazil.
Gopal Kedihithlu MaratheDepartment of Studies in Biochemistry, University of Mysore, Manasagangothri, Mysore, 570 006, India. marathe1962@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSepsis is a complex inflammatory disorder believed to originate from an infection by any types of microbes and/or their products. It is the leading cause of death in intensive care units (ICUs) throughout the globe. The mortality rates depend both on the severity of infection and the host's response to infection.

methodsLiterature survey on pathobiology of sepsis in general and failure of more than hundred clinical trials conducted so far in search of a possible cure for sepsis resulted in the preparation of this manuscript.

findingsSepsis lacks a suitable animal model that mimics human sepsis. However, based on the results obtained in animal models of sepsis, clinical trials conducted so far have been disappointing. Although involvement of multiple mediators and pathways in sepsis has been recognized, only few components are being targeted and this could be the major reason behind the failure of clinical trials.

conclusionInability to recognize a single critical mediator of sepsis may be the underlying cause for the poor therapeutic intervention of sepsis. Therefore, sepsis is still considered as a disease-in search of cure.

Indexed as

SepsisAnimalsAnti-Bacterial AgentsBacterial ProteinsDisease Models, AnimalHumansLipopolysaccharidesAnti-Bacterial AgentsBacterial ProteinsLipopolysaccharidesActivated protein CCytokinesLipopolysaccharide (LPS)SepsisToll-like receptors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.